Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Path Holdings (BPTH)

Bio-Path Holdings (BPTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bio-Path Holdings 625 Stanwix St. #2407 Pittsburgh PA 15222 USA

www.biopathholdings.com Employees: 10 P: 832-742-1357

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout the human body, via simple intravenous infusion. The delivery technology can be applied both to double stranded and single stranded nucleic acid compounds with the potential to revolutionize the treatment of cancer and other diseases where drugable targets of disease are well characterized.

Key Statistics

Overview:

Market Capitalization, $K 503
Enterprise Value, $K -667
Shares Outstanding, K 9,242
Float, K 9,176
% Float 99.28%
Short Interest, K 2
Short Float 0.03%
Days to Cover 1.00
Short Volume Ratio 0.00
% of Insider Shareholders 0.72%
% of Institutional Shareholders 5.74%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -9,890 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -980 K
EBIT, $ -10,920 K
EBITDA, $ -10,760 K

Growth:

1-Year Return -93.54%
3-Year Return -99.88%
5-Year Return -99.93%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 93.64%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.55 on 08/14/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -1.06
EPS Growth vs. Prev Qtr 80.00%
EPS Growth vs. Prev Year 87.36%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 02/23/24

BPTH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -595.05%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.87
Interest Coverage -1.10
60-Month Beta -0.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar